Tal Medical says it raised $14 million for its low-field magnetic stimulation technology, which is designed to be a non-invasive treatment for depression and bipolar disorder.
Tal Medical said today that it landed a $14 million Series B round it plans to use in backing clinical trials for its low-field magnetic stimulation technology as a non-invasive neurostimulation treatment for depression and bipolar disorder.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1cUVQUN
Cap comentari:
Publica un comentari a l'entrada